The global Ophthalmic Disease Therapeutics Market is projected to reach USD 53.8 billion by 2030, with a CAGR of 6.10% in the forecast period, driven by factors such as the increasing prevalence of ophthalmic diseases and advancements in treatment options.
The ASEAN medical diagnostics market is projected to reach a value of US$16.36 billion by 2027, driven by factors such as an increasing geriatric population, rising stress levels, growing healthcare expenditure, expanding urbanization, and a surging prevalence of western-type diseases in Southeast Asian countries.
The global dermatology market is projected to grow by USD 12.76 billion from 2022 to 2027, with a CAGR of 10.82%, driven by the increasing prevalence of teledermatology and the growing demand for telemedicine, making dermatology care more accessible.
The global neuroscience antibodies and assays market is projected to grow by USD 1.83 billion from 2022 to 2027, with North America contributing significantly to the market's growth due to the rising need for diagnosing neurological disorders.
